Niamh Alix
Personalreferent bei PRIME MEDICINE, INC.
Aktive Positionen von Niamh Alix
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRIME MEDICINE, INC. | Personalreferent | 01.06.2022 | - |
Karriereverlauf von Niamh Alix
Ehemalige bekannte Positionen von Niamh Alix
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01.08.2020 | 01.07.2022 |
Ausbildung von Niamh Alix
| Dublin City University | Graduate Degree |
| Technological University Dublin | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
| Irland | 2 |
Operativ
| Human Resources Officer | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Niamh Alix
- Erfahrung
